Sartorius Stedim Biotech S.A.
SDMHF
$192.00
$0.500.26%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 55.06M | 77.74M | 90.08M | 48.61M | |
| Total Depreciation and Amortization | 36.79M | 88.41M | 81.45M | 40.93M | |
| Total Amortization of Deferred Charges | 60.88M | -- | -- | 44.98M | |
| Total Other Non-Cash Items | 65.07M | 40.18M | -8.94M | 21.53M | |
| Change in Net Operating Assets | 69.15M | -64.58M | -36.52M | 147.64M | |
| Cash from Operations | 286.95M | 141.75M | 126.07M | 303.69M | |
| Capital Expenditure | -136.32M | -86.14M | -68.72M | -85.28M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -1.13M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -1.98M | -- | -- | -213.20K | |
| Cash from Investing | -138.29M | -87.28M | -68.72M | -85.49M | |
| Total Debt Issued | 400.00K | 12.90M | -- | 3.70M | |
| Total Debt Repaid | 0.00 | 0.00 | -13.70M | -9.10M | |
| Issuance of Common Stock | 4.20M | 1.10M | -- | 2.80M | |
| Repurchase of Common Stock | -- | -- | -2.00M | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | 0.00 | -76.15M | -- | 0.00 | |
| Other Financing Activities | -3.70M | -200.00K | -9.90M | -8.80M | |
| Cash from Financing | 1.05M | -60.49M | -26.94M | -12.15M | |
| Foreign Exchange rate Adjustments | -1.40M | -3.40M | -315.70K | 3.30M | |
| Miscellaneous Cash Flow Adjustments | -- | -113.50K | 105.20K | -- | |
| Net Change in Cash | 148.31M | -9.53M | 30.20M | 209.36M | |